Pepinemab manufacturers
- Pepinemab
-
- $198.00
-
2026-09-10
- CAS:2097151-87-4
- Purity: 97.00%
- Supply Ability: 10g
|
| | Pepinemab Basic information |
| Product Name: | Pepinemab | | Synonyms: | Pepinemab;Research Grade Pepinemab(DHJ33901);VX 15/2503;Research Grade Pepinemab | | CAS: | 2097151-87-4 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Pepinemab Structure]() |
| | Pepinemab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Pepinemab Usage And Synthesis |
| Uses | Pepinemab (VX 15/2503) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), also known as CD100, which is a regulator of neuronal development and plays a role in a variety of cellular processes. Pepinemab can be used in the study of various neurodegenerative diseases such as Alzheimer's disease by blocking the activity of SEMA4D[1]. | | References | [1] Elizabeth E Evans, et al. Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity. J Neuroinflammation. 2022 Aug 6;19(1):200. DOI:10.1186/s12974-022-02509-8 |
| | Pepinemab Preparation Products And Raw materials |
|